Multi-photon microscopy

Linking drug mechanism to disease physiology

Brian W. Grinnell, Akanksha Gupta, Ruben M. Sandoval, Bruce Molitoris

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

While intravital microscopy has been a valuable tool of the cell biologist for many years, its capabilities have been significantly advanced with the recent development of multi-photon microscopy. When combined with specialized methods of small animal surgery, intravital multi-photon microscopy provides the ability to quantify the cellular and subcellular distribution of drugs and to directly measure physiological processes in internal organs such as the liver, kidney, intestine and brain. Intravital multi-photon microscopy combines the resolution of microscopy with the relevance of in vivo imaging, resulting in studies that yield unique insights into the effects and distribution of pharmaceutical compounds, and studies that may better predict product safety and efficacy. Advancements in many areas of microscopy, probe development, software and hardware development have occurred to enable the present state technology, and the ability to apply these to in vivo study represents a new era in biology and pharmacology that will lead to enhanced understanding of physiologic and disease processes. In summary, multi-photon microscopy holds great promise to the biopharmaceutical industry by allowing a better link between in vitro biology and in vivo disease pathophysiology, which will hopefully increase the translation of preclinical drug evaluation to clinical outcomes.

Original languageEnglish
JournalAmerican Pharmaceutical Review
Volume10
Issue number6
StatePublished - Nov 2007

Fingerprint

Photons
Microscopy
Pharmaceutical Preparations
Physiological Phenomena
Preclinical Drug Evaluations
Intestines
Industry
Software
Pharmacology
Technology
Kidney
Safety
Liver
Brain

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Multi-photon microscopy : Linking drug mechanism to disease physiology. / Grinnell, Brian W.; Gupta, Akanksha; Sandoval, Ruben M.; Molitoris, Bruce.

In: American Pharmaceutical Review, Vol. 10, No. 6, 11.2007.

Research output: Contribution to journalArticle

Grinnell, Brian W. ; Gupta, Akanksha ; Sandoval, Ruben M. ; Molitoris, Bruce. / Multi-photon microscopy : Linking drug mechanism to disease physiology. In: American Pharmaceutical Review. 2007 ; Vol. 10, No. 6.
@article{a7cc9828fa1b4bd893f15f6e6c9b7d24,
title = "Multi-photon microscopy: Linking drug mechanism to disease physiology",
abstract = "While intravital microscopy has been a valuable tool of the cell biologist for many years, its capabilities have been significantly advanced with the recent development of multi-photon microscopy. When combined with specialized methods of small animal surgery, intravital multi-photon microscopy provides the ability to quantify the cellular and subcellular distribution of drugs and to directly measure physiological processes in internal organs such as the liver, kidney, intestine and brain. Intravital multi-photon microscopy combines the resolution of microscopy with the relevance of in vivo imaging, resulting in studies that yield unique insights into the effects and distribution of pharmaceutical compounds, and studies that may better predict product safety and efficacy. Advancements in many areas of microscopy, probe development, software and hardware development have occurred to enable the present state technology, and the ability to apply these to in vivo study represents a new era in biology and pharmacology that will lead to enhanced understanding of physiologic and disease processes. In summary, multi-photon microscopy holds great promise to the biopharmaceutical industry by allowing a better link between in vitro biology and in vivo disease pathophysiology, which will hopefully increase the translation of preclinical drug evaluation to clinical outcomes.",
author = "Grinnell, {Brian W.} and Akanksha Gupta and Sandoval, {Ruben M.} and Bruce Molitoris",
year = "2007",
month = "11",
language = "English",
volume = "10",
journal = "American Pharmaceutical Review",
issn = "1099-8012",
publisher = "Russell Publishing LLC",
number = "6",

}

TY - JOUR

T1 - Multi-photon microscopy

T2 - Linking drug mechanism to disease physiology

AU - Grinnell, Brian W.

AU - Gupta, Akanksha

AU - Sandoval, Ruben M.

AU - Molitoris, Bruce

PY - 2007/11

Y1 - 2007/11

N2 - While intravital microscopy has been a valuable tool of the cell biologist for many years, its capabilities have been significantly advanced with the recent development of multi-photon microscopy. When combined with specialized methods of small animal surgery, intravital multi-photon microscopy provides the ability to quantify the cellular and subcellular distribution of drugs and to directly measure physiological processes in internal organs such as the liver, kidney, intestine and brain. Intravital multi-photon microscopy combines the resolution of microscopy with the relevance of in vivo imaging, resulting in studies that yield unique insights into the effects and distribution of pharmaceutical compounds, and studies that may better predict product safety and efficacy. Advancements in many areas of microscopy, probe development, software and hardware development have occurred to enable the present state technology, and the ability to apply these to in vivo study represents a new era in biology and pharmacology that will lead to enhanced understanding of physiologic and disease processes. In summary, multi-photon microscopy holds great promise to the biopharmaceutical industry by allowing a better link between in vitro biology and in vivo disease pathophysiology, which will hopefully increase the translation of preclinical drug evaluation to clinical outcomes.

AB - While intravital microscopy has been a valuable tool of the cell biologist for many years, its capabilities have been significantly advanced with the recent development of multi-photon microscopy. When combined with specialized methods of small animal surgery, intravital multi-photon microscopy provides the ability to quantify the cellular and subcellular distribution of drugs and to directly measure physiological processes in internal organs such as the liver, kidney, intestine and brain. Intravital multi-photon microscopy combines the resolution of microscopy with the relevance of in vivo imaging, resulting in studies that yield unique insights into the effects and distribution of pharmaceutical compounds, and studies that may better predict product safety and efficacy. Advancements in many areas of microscopy, probe development, software and hardware development have occurred to enable the present state technology, and the ability to apply these to in vivo study represents a new era in biology and pharmacology that will lead to enhanced understanding of physiologic and disease processes. In summary, multi-photon microscopy holds great promise to the biopharmaceutical industry by allowing a better link between in vitro biology and in vivo disease pathophysiology, which will hopefully increase the translation of preclinical drug evaluation to clinical outcomes.

UR - http://www.scopus.com/inward/record.url?scp=55749085868&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=55749085868&partnerID=8YFLogxK

M3 - Article

VL - 10

JO - American Pharmaceutical Review

JF - American Pharmaceutical Review

SN - 1099-8012

IS - 6

ER -